Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-16

FDA Approved: EXEMESTANE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Exemestane from Mylan Pharmaceuticals, finalizing approval of a generic Exemestane product. The action expands a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)